plasma
-
not specified
Microarray; RNase R Treatment; RT-qPCR; Clinical Sample Validation; ROC Analysis; Bioinformatics Analysis
CRC-specific biomarker for early diagnosis; high diagnostic ability to predict CRC from CRA patients and healthy controls
hsa_circ_105039 is increased in CRC plasma and is part of a three-circRNA circulating panel that distinguishes CRC from CRA and healthy controls with high AUC. The study did not experimentally define its CRC mechanism.
0.5963
Circulating cell-free circRNA panel predicted tumorigenesis and development of colorectal cancer.
combined biological and clinical study